DSP Aims to Enhance Its Presence in Field of Oncology by Developing First-in-Class Drugs

Dainippon Sumitomo Pharma (DSP) aims to enhance its presence in the global market for oncology by developing innovative first-in-class anticancer agents. The company will accelerate the development of drugs in the pipeline, which DSP acquired through its acquisition of the...read more